S&D Co., Ltd (KOSDAQ:260970)

Market Cap	351.47B
Revenue (ttm)	128.03B
Net Income (ttm)	18.59B
Shares Out	2.89M
EPS (ttm)	6,305.33
PE Ratio	19.27
Forward PE	14.42
Dividend	800.00 (0.64%)
Ex-Dividend Date	Dec 27, 2024

Volume	18,768
Average Volume	57,215
Open	124,400
Previous Close	125,900
Day's Range	121,400 - 125,300
52-Week Range	28,650 - 149,800
Beta	0.97
RSI	49.73
Earnings Date	Aug 14, 2025

About S&D Co., Ltd

S&D Co., Ltd develops and sells health functional food in South Korea. The company offers general functional food ingredients, health-oriented functional ingredients, and biological industry materials for the sleeping problems and glycoconjugate gastric functions. It provides health-oriented functional ingredients, such as Lindera glauca extract, Rice bran Extract, MPG-6/MPGT, RCS, and Xanthorrhizol, as well as other materials, including Pagopyridol, SD 1002F, and Panduratin. The company also offers general functional food ingredients comprisin...

• Industry: Miscellaneous Food Preparations And Kindred Products
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 260970

Financial Performance

In 2024, S&D Co., Ltd's revenue was 116.14 billion, an increase of 31.56% compared to the previous year's 88.28 billion. Earnings were 17.03 billion, an increase of 43.45%.